Suppr超能文献

曲安奈德注射液联合激光光凝治疗糖尿病黄斑水肿的疗效及安全性:系统评价和荟萃分析。

Efficacy and safety of triamcinolone acetonide injection combined with laser photocoagulation in the treatment of diabetic macular edema: a systematic review and meta-analysis.

机构信息

Department of Ophthalmology, Shengjing Hospital of China Medical University, Shenyang, China.

出版信息

Ann Palliat Med. 2021 Dec;10(12):12467-12477. doi: 10.21037/apm-21-3274.

Abstract

BACKGROUND

Diabetic macular edema (DME) is a type of retinopathy caused by diabetes, and the 2 main clinical treatment modalities are drug therapy intravitreal triamcinolone acetonide injection (IVTA) and laser photocoagulation. This meta-analysis investigated the efficacy of combining both the 2 treatment modalities.

METHODS

The Embase, Cochrane library, PubMed, and Ovid databases were searched for English literatures. The literatures were screened and assessed for the risk of bias, after that the Revman 5.4 software was used to conduct the meta-analysis.

RESULTS

A total of 8 articles, including 549 patients, were included in this study. Meta-analysis showed that the effect of (IVTA + laser) on early central macular thickness (CMT) was not significantly different with IVTA alone [mean difference (MD) =-5.13, 95% confidence interval (CI): -17.06 to 6.80, P=0.40], however, significantly different with laser alone (MD =-94.31, 95% CI: -135.04 to -53.58, P<0.00001). Similarly, the effect of (IVTA + laser) on early best corrected visual acuity (BCVA) was not significantly different with IVTA alone (MD =0.02, 95% CI: -0.03 to 0.07, Z=0.79, P=0.43). but different with laser alone [MD =-0.20, 95% CI: -0.24 to -0.16, Z=10.16, P<0.00001). The effect of (IVTA + laser) on long-term CMT was not significantly different with IVTA alone (MD =-66.90, 95% CI: -132.66 to -1.15, Z=1.99, P=0.05) nor with laser alone (MD =-15.86, 95% CI: -31.37 to -0.35, Z=2.00, P=0.05). Similarly, the effect of combined intervention (IVTA + laser) on long-term BCVA was not significantly different with IVTA alone (MD =-0.18, 95% CI: -0.39 to 0.03, Z=1.71, P=0.09) nor with laser alone (MD =-0.11, 95% CI: -0.23 to 0.01, Z=1.74, P=0.08). Administration of IVTA before laser was superior to laser alone (MD =-0.19, 95% CI: -0.31 to -0.07, Z=3.09, P=0.002).

DISCUSSION

The effect of IVTA + laser therapy is similar to IVTA alone, but superior to laser alone for the early treatment of DME. However, the long-term effect is similar to IVTA alone or laser alone, a better therapeutic effect can be achieved if IVTA is administered before laser treatment.

摘要

背景

糖尿病性黄斑水肿(DME)是一种由糖尿病引起的视网膜病变,其 2 种主要临床治疗方式是药物治疗——玻璃体内曲安奈德注射(IVTA)和激光光凝。本荟萃分析研究了联合使用这 2 种治疗方法的疗效。

方法

在 Embase、Cochrane 图书馆、PubMed 和 Ovid 数据库中检索英文文献。筛选文献并评估偏倚风险,然后使用 Revman 5.4 软件进行荟萃分析。

结果

共有 8 篇文章,包括 549 名患者,纳入本研究。荟萃分析显示,(IVTA+激光)治疗早期中央黄斑厚度(CMT)的效果与单独使用 IVTA 无显著差异[平均差值(MD)=-5.13,95%置信区间(CI):-17.06 至 6.80,P=0.40],但与单独使用激光有显著差异(MD=-94.31,95%CI:-135.04 至-53.58,P<0.00001)。同样,(IVTA+激光)治疗早期最佳矫正视力(BCVA)的效果与单独使用 IVTA 无显著差异(MD=0.02,95%CI:-0.03 至 0.07,Z=0.79,P=0.43),但与单独使用激光有显著差异[MD=-0.20,95%CI:-0.24 至-0.16,Z=10.16,P<0.00001)。(IVTA+激光)治疗长期 CMT 的效果与单独使用 IVTA 无显著差异(MD=-66.90,95%CI:-132.66 至-1.15,Z=1.99,P=0.05),与单独使用激光也无显著差异(MD=-15.86,95%CI:-31.37 至-0.35,Z=2.00,P=0.05)。同样,联合干预(IVTA+激光)治疗长期 BCVA 的效果与单独使用 IVTA 无显著差异(MD=-0.18,95%CI:-0.39 至 0.03,Z=1.71,P=0.09),与单独使用激光也无显著差异(MD=-0.11,95%CI:-0.23 至 0.01,Z=1.74,P=0.08)。IVTA 联合激光治疗优于单独激光治疗(MD=-0.19,95%CI:-0.31 至-0.07,Z=3.09,P=0.002)。

讨论

IVTA+激光治疗的效果与单独使用 IVTA 相似,但优于单独使用激光治疗 DME 的早期。然而,长期效果与单独使用 IVTA 或激光相似,如果在激光治疗前先使用 IVTA,则可以获得更好的治疗效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验